Market Analysis
The global veterinary clostridium vaccine market size is expected to reach USD 423.29 Million by 2030 at 4.2% CAGR during the forecast period 2022-2030, reveals the new Market Research Future (MRFR) report. Clostridium bacteria are anaerobic in nature. They are mostly found in the gut of animals and humans, and in soil. Vaccination plays a pivotal part in protecting animals against this disease. Generally, these vaccines are used for animals like poultry, caprine, swine, ovine, bovine, and others. Such vaccines come in different varieties, including combinations and single vaccines. The combination vaccines comprise toxoids, bacterins, or a mixture of toxoids and bacterins.
Various factors are adding to the global veterinary clostridium vaccine market share. The different veterinary clostridium vaccine market drivers, as per the new MRFR report, include rising consumption of products that are animal-derived, technological advances, increasing prevalence if clostridium family diseases, growing awareness about zoonotic diseases, and rise in disposable income. On the other hand, the rising consumption of milk and meat are impacting the human vaccines market.
On the contrary, strict regulations, high treatment costs, and certain side effects are factors that may limit the global animal clostridium vaccine market growth over the forecast period.
Market Segmentation
The Market Research Future Report provides an inclusive segmental analysis of the global veterinary clostridium vaccine market outlook, based on distribution channels and animal type.
By type, the global veterinary clostridium vaccine market is segmented into poultry, caprine, swine, ovine, bovine, and others. Of these, the bovine segment will lead the market over the forecast period.
By distribution channels, the global veterinary clostridium vaccine market is segmented into retail pharmacy, veterinary research institute, veterinary clinic, and veterinary hospital. Of these, the veterinary hospital segment will dominate the market over the forecast period.
Regional Analysis
Based on the region, the global veterinary clostridium vaccine market insights report covers the recent trends and growth opportunities across Europe, the Americas, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will have the lions share in the market over the forecast period. Factors propelling the market growth include increasing disposable income, growing awareness about animal-derived products, increasing prevalence of clostridium family diseases, growing awareness about zoonotic diseases, and the presence of top industry players. Besides, decreasing arable land, growing demand for meat products, and the rising prevalence of black diseases & blackleg diseases are also adding market growth in the region.
The veterinary clostridium vaccine market in Europe is predicted to possess the second-largest share over the forecast period for the growing awareness about various veterinary clostridium vaccine products, growing awareness about zoonotic diseases, and increasing demand for livestock products. The UK and Germany are the key contributors in the region.
The veterinary clostridium vaccine market in the APAC region is predicted to grow at a fast pace over the forecast period for increased government initiatives, growing population in India & China that is boosting the demand for meat products, increasing incidence of clostridial diseases, rise in disposable income, and growing awareness regarding clostridium vaccine products.
The veterinary clostridium vaccine market in the MEA is predicted to have the smallest share over the forecast period.
Key Players
The global veterinary clostridium vaccine market players report include Bayer AG (Germany), Elanco Animal Health (US), Zoetis (US), Valneva SE (France), Virbac (Australia), Colorado Serum Company (US), Boehringer Ingelheim International GmbH (Germany), Ceva Santé Animale (France), and Merck & Co., Inc. (US). Key players have incorporated strategies such as contracts, geographic expansions, mergers and acquisitions, product launches, and strategic alliances, among others, to create a niche in the market and also cater to customers growing needs.
About US:
Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013